SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
AMENDMENT NO. 1 TO
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) JANUARY 5, 2005
---------------------------
EMRISE CORPORATION
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 001-10346 77-0226211
---------------------------- --------- ----------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
9485 HAVEN AVENUE, SUITE 100, RANCHO CUCAMONGA, CALIFORNIA 91730
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (909) 987-9220
------------------------------
NOT APPLICABLE
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (SEE General Instruction A.2. below):
|_| Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 8.01. OTHER EVENTS.
As described in a Form 8-K for December 29, 2004, Emrise Corporation
entered into a Securities Purchase Agreement and a Registration Rights Agreement
on that date. The Securities Purchase Agreement provides for the issuance by
Emrise to 17 record holders in a private offering an aggregate of 12,503,500
shares of common stock of Emrise at a purchase price of $1.44 per share and
five-year investor warrants to purchase up to an additional 3,125,875 shares
of common stock of Emrise at an exercise price of $1.73 per share.
Emrise has agreed to pay cash placement agent fees of approximately
$936,500 and issued five-year placement agent warrants to purchase up to
an aggregate of 650,310 shares of common stock of Emrise in connection with
the offering. The purpose of this Form 8-K is to announce that the closing of
the transactions contemplated by the Securities Purchase Agreement occurred
on January 5, 2005.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: January 6, 2005 EMRISE CORPORATION
By: /S/ RANDOLPH D. FOOTE
------------------------------------------
Randolph D. Foote, Chief Financial Officer
3